Watchlist Price Alert

Champions Oncology Inc. (CSBR)

NASDAQ: CSBR · Real-Time Price · USD

6.91

0.41 (6.31%)

At close: Jun 06, 2025, 3:59 PM

6.89

-0.29%

After-hours: Jun 06, 2025, 04:04 PM EDT

6.31% (1D)

Bid	6.08
Market Cap	95.54M
Revenue (ttm)	58.59M
Net Income (ttm)	6.43M
EPS (ttm)	0.45
PE Ratio (ttm)	15.36
Forward PE	29.41
Analyst	Strong Buy

Ask	8.94
Volume	10,333
Avg. Volume (20D)	37,671
Open	6.84
Previous Close	6.50
Day's Range	6.82 - 6.91
52-Week Range	3.60 - 11.99
Beta	0.37

About CSBR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CSBR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CSBR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

5 months ago

+12.09%

Champions Oncology shares are trading higher after... Unlock content with Pro Subscription

8 months ago

+9.58%

Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price target.

News

1 month ago · accessnewswire.com

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinica...

2 months ago · seekingalpha.com

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR ) Q3 2025 Earnings Conference Call March 11, 2025 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Maj Soueidan...

2 months ago · accessnewswire.com

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, toda...

3 months ago · accessnewswire.com

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

HACKENSACK, NJ / ACCESS Newswire / March 6, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will ...